NCT00953888View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy
Interventions
DRUG

AZD5069

Single dose of oral solution.

DRUG

Placebo

Single dose of oral solution.

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY